{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T11:09:59Z","timestamp":1768993799641,"version":"3.49.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern Emerg Med"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s11739-011-0688-2","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T17:10:24Z","timestamp":1318957824000},"page":"77-83","source":"Crossref","is-referenced-by-count":20,"title":["Management of patients with chronic kidney disease"],"prefix":"10.1007","volume":"6","author":[{"given":"Francesco P.","family":"Schena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,10,19]]},"reference":[{"issue":"Suppl 1","key":"688_CR1","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 1):S1\u2013S266","journal-title":"Am J Kidney Dis"},{"key":"688_CR2","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1681\/ASN.2004070549","volume":"16","author":"M Froissart","year":"2005","unstructured":"Froissart M, Rossert J, Jacquot C, Paillard M, Houillier P (2005) Predictive performance of the modification of diet in renal disease and Cockcroft-Gault equations for estimating renal function. J Am Soc Nephrol 16:763\u2013773","journal-title":"J Am Soc Nephrol"},{"key":"688_CR3","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","volume":"354","author":"LA Stevens","year":"2006","unstructured":"Stevens LA, Coresh J, Greene T, Levey AS (2006) Assessing kidney function\u2013measured and estimated glomerular filtration rate. N Engl J Med 354:2473\u20132483","journal-title":"N Engl J Med"},{"key":"688_CR4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/ki.2008.638","volume":"75","author":"LA Stevens","year":"2009","unstructured":"Stevens LA, Schmid CH, Greene T, Li L, Beck GJ, Joffe MM, Froissart M, Kusek JW, Zhang YL, Coresh J, Levey AS (2009) Factors other than glomerular filtration rate affect serum cystatin C levels. Kidney Int 75:652\u2013660","journal-title":"Kidney Int"},{"key":"688_CR5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1016\/S0140-6736(98)04433-X","volume":"352","author":"P Ruggenenti","year":"1998","unstructured":"Ruggenenti P, Perna A, Gherardi G, Gaspari F, Benini R, Remuzzi G (1998) Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy. Lancet 352:1252\u20131256","journal-title":"Lancet"},{"key":"688_CR6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1053\/j.ajkd.2004.03.027","volume":"44","author":"S Hallan","year":"2004","unstructured":"Hallan S, Asberg A, Lindberg M, Johnsen H (2004) Validation of the Modification of Diet in Renal Disease formula for estimating GFR with special emphasis on calibration of the serum creatinine assay. Am J Kidney Dis 44:84\u201393","journal-title":"Am J Kidney Dis"},{"issue":"Suppl 2","key":"688_CR7","first-page":"S1","volume":"39","author":"National Kidney Foundation","year":"2002","unstructured":"National Kidney Foundation (2002) KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39(Suppl 2):S1\u2013S266","journal-title":"Am J Kidney Dis"},{"key":"688_CR8","doi-asserted-by":"crossref","first-page":"F639","DOI":"10.1152\/ajprenal.00737.2010","volume":"300","author":"MD Carattino","year":"2011","unstructured":"Carattino MD, Passero CJ (2011) Clues to renal sodium retention. Am J Physiol Renal Physiol 300:F639\u2013F640","journal-title":"Am J Physiol Renal Physiol"},{"key":"688_CR9","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1681\/ASN.2009010104","volume":"20","author":"ME Choi","year":"2009","unstructured":"Choi ME (2009) The not-so-sweet side of fructose. J Am Soc Nephrol 20:457\u2013459","journal-title":"J Am Soc Nephrol"},{"key":"688_CR10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1681\/ASN.V72306","volume":"7","author":"B Cianciaruso","year":"1996","unstructured":"Cianciaruso B, Bellizzi V, Minutolo R, Colucci G, Bisesti V, Russo D, Conte G, De Nicola L (1996) Renal adaptation to dietary sodium restriction in moderate renal failure resulting from chronic glomerular disease. J Am Soc Nephrol 7:306\u2013313","journal-title":"J Am Soc Nephrol"},{"key":"688_CR11","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2215\/CJN.04750908","volume":"4","author":"SD Navaneethan","year":"2009","unstructured":"Navaneethan SD, Nigwekar SU, Sehgal AR, Strippoli GF (2009) Aldosterone antagonists for preventing the progression of chronic kidney disease: a systematic review and meta-analysis. Clin J Am Soc Nephrol 4:542\u2013551","journal-title":"Clin J Am Soc Nephrol"},{"key":"688_CR12","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.0894-0959.2004.17311.x","volume":"17","author":"S Beddhu","year":"2004","unstructured":"Beddhu S (2004) The body mass index paradox and an obesity, inflammation, and atherosclerosis syndrome in chronic kidney disease. Semin Dial 17:229\u2013232","journal-title":"Semin Dial"},{"key":"688_CR13","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7326\/0003-4819-141-2-200407200-00007","volume":"141","author":"CY Hsu","year":"2004","unstructured":"Hsu CY, Vittinghoff E, Lin F, Shlipak MG (2004) The incidence of end-stage renal disease is increasing faster than the prevalence of chronic renal insufficiency. Ann Intern Med 141:95\u2013101","journal-title":"Ann Intern Med"},{"key":"688_CR14","doi-asserted-by":"crossref","unstructured":"Hallan SI, Orth SR (2011) Smoking is a risk factor in the progression to kidney failure. Kidney Int [Epub ahead of print]","DOI":"10.1038\/ki.2011.157"},{"key":"688_CR15","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1161\/01.CIR.0000143892.84582.60","volume":"110","author":"M Tonelli","year":"2004","unstructured":"Tonelli M, Isles C, Curhan GC, Tonkin A, Pfeffer MA, Shepherd J, Sacks FM, Furberg C, Cobbe SM, Simes J, Craven T, West M (2004) Effect of pravastatin on cardiovascular events in people with chronic kidney disease. Circulation 110:1557\u20131563","journal-title":"Circulation"},{"key":"688_CR16","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/j.ajkd.2008.11.021","volume":"53","author":"M Arici","year":"2009","unstructured":"Arici M, Erdem Y (2009) Dual blockade of the renin-angiotensin system for cardiorenal protection: an update. Am J Kidney Dis 53:332\u2013345","journal-title":"Am J Kidney Dis"},{"key":"688_CR17","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11906-009-0022-9","volume":"11","author":"P Cravedi","year":"2009","unstructured":"Cravedi P, Ruggenenti P, Remuzzi G (2009) Intensified inhibition of renin-angiotensin system: a way to improve renal protection? Curr Hypertens Rep 11:118\u2013124","journal-title":"Curr Hypertens Rep"},{"key":"688_CR18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","volume":"334","author":"G Maschio","year":"1996","unstructured":"Maschio G, Alberti D, Janin G, Locatelli F, Mann JF, Motolese M, Ponticelli C, Ritz E, Zucchelli P (1996) Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group. N Engl J Med 334:939\u2013945","journal-title":"N Engl J Med"},{"key":"688_CR19","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMvcm0800666","volume":"359","author":"S Anderson","year":"2008","unstructured":"Anderson S, Komers R (2008) Aliskiren combined with losartan in diabetes and nephropathy. N Engl J Med 359:1069","journal-title":"N Engl J Med"},{"key":"688_CR20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00041552-200403000-00003","volume":"13","author":"CN Gashti","year":"2004","unstructured":"Gashti CN, Bakris GL (2004) The role of calcium antagonists in chronic kidney disease. Curr Opin Nephrol Hypertens 13:155\u2013161","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"688_CR21","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1038\/sj.ki.5001835","volume":"70","author":"GL Bakris","year":"2006","unstructured":"Bakris GL, Hart P, Ritz E (2006) Beta blockers in the management of chronic kidney disease. Kidney Int 70:1905\u20131913","journal-title":"Kidney Int"},{"key":"688_CR22","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2215\/CJN.01580210","volume":"5","author":"M Goicoechea","year":"2010","unstructured":"Goicoechea M, de Vinuesa SG, Verdalles U, Ruiz-Caro C, Ampuero J, Rinc\u00f3n A, Arroyo D, Lu\u00f1o J (2010) Effect of allopurinol in chronic kidney disease progression and cardiovascular risk. Clin J Am Soc Nephrol 5:1388\u20131393","journal-title":"Clin J Am Soc Nephrol"},{"key":"688_CR23","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1067\/mhj.2002.125513","volume":"144","author":"PA McCullough","year":"2002","unstructured":"McCullough PA, Sandberg KR, Borzak S, Hudson MP, Garg M, Manley HJ (2002) Benefits of aspirin and beta-blockade after myocardial infarction in patients with chronic kidney disease. Am Heart J 144:226\u2013232","journal-title":"Am Heart J"},{"key":"688_CR24","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa010323","volume":"345","author":"CM Fored","year":"2001","unstructured":"Fored CM, Ejerblad E, Lindblad P, Fryzek JP, Dickman PW, Signorello LB, Lipworth L, Elinder CG, Blot WJ, McLaughlin JK, Zack MM, Nyr\u00e9n O (2001) Acetaminophen, aspirin, and chronic renal failure. N Engl J Med 345:1801\u20131808","journal-title":"N Engl J Med"},{"key":"688_CR25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1053\/j.ajkd.2008.08.009","volume":"53","author":"V Menon","year":"2009","unstructured":"Menon V, Kopple JD, Wang X, Beck GJ, Collins AJ, Kusek JW, Greene T, Levey AS, Sarnak MJ (2009) Effect of a very low-protein diet on outcomes: long-term follow-up of the Modification of Diet in Renal Disease (MDRD) Study. Am J Kidney Dis 53:208\u2013217","journal-title":"Am J Kidney Dis"},{"key":"688_CR26","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1038\/sj.ki.5001695","volume":"70","author":"AM Thompson","year":"2006","unstructured":"Thompson AM, Pickering TG (2006) The role of ambulatory blood pressure monitoring in chronic and end-stage renal disease. Kidney Int 70:1000\u20131007","journal-title":"Kidney Int"},{"key":"688_CR27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrneph.2010.127","volume":"6","author":"JC Fink","year":"2010","unstructured":"Fink JC (2010) Chronic kidney disease: the effect of CKD therapies on serum potassium levels. Nat Rev Nephrol. 6:633\u2013634","journal-title":"Nat Rev Nephrol."},{"key":"688_CR28","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1681\/ASN.2004070597","volume":"16","author":"DE Weiner","year":"2005","unstructured":"Weiner DE, Tighiouart H, Vlagopoulos PT, Griffith JL, Salem DN, Levey AS, Sarnak MJ (2005) Effects of anemia and left ventricular hypertrophy on cardiovascular disease in patients with chronic kidney disease. J Am Soc Nephrol 16:1803\u20131810","journal-title":"J Am Soc Nephrol"},{"key":"688_CR29","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1542-4758.2008.00233.x","volume":"12","author":"SD Weisbord","year":"2008","unstructured":"Weisbord SD, Kimmel PL (2008) Health-related quality of life in the era of erythropoietin. Hemodial Int 12:6\u201315","journal-title":"Hemodial Int"},{"key":"688_CR30","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0140-6736(07)60194-9","volume":"369","author":"A Phrommintikul","year":"2007","unstructured":"Phrommintikul A, Haas SJ, Elsik M, Krum H (2007) Mortality and target haemoglobin concentrations in anaemic patients with chronic kidney disease treated with erythropoietin: a meta-analysis. Lancet 369:381\u2013388","journal-title":"Lancet"},{"key":"688_CR31","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/S0140-6736(07)60165-2","volume":"369","author":"GF Strippoli","year":"2007","unstructured":"Strippoli GF, Tognoni G, Navaneethan SD, Nicolucci A, Craig JC (2007) Haemoglobin targets: we were wrong, time to move on. Lancet 369:346\u2013350","journal-title":"Lancet"},{"key":"688_CR32","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Dr\u00fceke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int 69:1945\u20131953","journal-title":"Kidney Int"},{"key":"688_CR33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1111\/j.1523-1755.2004.00481.x","volume":"65","author":"JA Eustace","year":"2004","unstructured":"Eustace JA, Astor B, Muntner PM, Ikizler TA, Coresh J (2004) Prevalence of acidosis and inflammation and their association with low serum albumin in chronic kidney disease. Kidney Int 65:1031\u20131040","journal-title":"Kidney Int"},{"key":"688_CR34","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1681\/ASN.2008111205","volume":"20","author":"I Brito-Ashurst de","year":"2009","unstructured":"de Brito-Ashurst I, Varagunam M, Raftery MJ, Yaqoob MM (2009) Bicarbonate supplementation slows progression of CKD and improves nutritional status. J Am Soc Nephrol 20:2075\u20132084","journal-title":"J Am Soc Nephrol"}],"container-title":["Internal and Emergency Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0688-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11739-011-0688-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11739-011-0688-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,11]],"date-time":"2021-12-11T15:51:42Z","timestamp":1639237902000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11739-011-0688-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":34,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["688"],"URL":"https:\/\/doi.org\/10.1007\/s11739-011-0688-2","relation":{},"ISSN":["1828-0447","1970-9366"],"issn-type":[{"value":"1828-0447","type":"print"},{"value":"1970-9366","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}